Clinical Trial

Impact of the NeuroCuple Device on Pain Management After Cesarean Delivery

Recruiting
View on ClinicalTrials.gov →
Summary
This will be a single-center, sham-controlled, 3 arms, randomized (1:1:1) prospective study in females undergoing cesarean delivery to investigate the impact of NeuroCuple™ non-pharmacological analgesic device for management of postoperative pain. The investigators hypothesize that women treated with the Neurocuple device will experience less pain and consequently require less opioid pain medication after cesarean delivery compared to women who receive standard post-surgical medication.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-15; most recent amendment 2025-10-14.
Status change: Not Yet Recruiting → Recruiting 2025-10-08
Trial Details
NCT Number NCT07185425
Lead Sponsor Inova Health Care Services
Collaborators: nCap Medical
Conditions Pain, Analgesia, Pregnancy
Enrollment 180 participants
Start Date 2025-10-13
Primary Completion 2027-09 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2025-10-16